LDS/Medical Tests/Lysosomal Acid Lipase, Gene Variation

Lysosomal Acid Lipase, Gene Variation

Lysosomal acid lipase is a hydrolase enzyme transcribed by the LIPA gene located at 10q23.1-3.3. The enzyme is present in the lysosome and is the only enzyme active in the acidic lysosomal pH. The enzyme holds an important role in lipid metabolism, being responsible for lipid hydrolysis and recycling by hydrolyses of lipids, specifically cholesteryl esters and triglycerides into free fatty acids and cholesterol.

More than 65 LIPA mutations have been reported in the literature to be associated with enzyme deficiency. The severe enzyme deficiency is typically caused by biallelic loss-of-function mutations that completely eliminates LAL enzymatic activity. The most prevalent genetic variant in European and Hispanic ancestry is variant c.894G>A (rs116928232), a synonymous exonic splice junction mutation that causes skipping of exon 8 resulting in deletion of 24 amino acids of the enzyme.

Mutations in the LIPA gene may result in diminished lysosomal acid lipase activity, leading to excessive accumulation of cholesteryl esters and triglycerides in cells which effect the normal functions of cells within the liver, adrenals and spleen. There are two syndromes associated with LIPA mutations depending on the age of clinical onset. Wolman disease appears in the first few weeks after birth and cholesteryl ester storage disease (CESD) appears later. In both disorders there is lipid accumulation in the liver, spleen and adrenal glands which may result in cirrhosis and adrenal insufficiency. Patients have high LDL levels and are prone to develop atherosclerosis. These disorders are inherited in an autosomal recessive fashion with an annual prevalence of 1 in 40,000 live births.

  • Useful in the diagnosis of lysosomal acid lipase deficiency
  • Useful in the investigation of dyslipidemia
  • Useful in screening neonates and family members at risk
Lysosomal acid lipase enzyme activity is decreased in LIPA gene mutations. Positive for mutation is suggestive of enzyme deficiency.

Negative for mutations analysis (no mutations or pathogenic variants detected)

Targeted variant analysis by next-generation sequencing (NGS) or polymerase chain reaction (PCR), whole-exome sequencing (WES) by NGS.

Whole blood, EDTA (Lavender-top tube).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7 days
Total cholesterol, LDL, HDL, triglycerides, Liver function tests, CBC with differential, serum cortisol, serum iron, ferritin, TIBC.
3 to 7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login